Home Healthcare IT Cancer Treatment Market Size, Analysis, Growth Report, Share, forecast period 2026

Cancer Treatment Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Others), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By End-users (Hospitals, Specialty Clinics, Cancer & Radiation Therapy Centers) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2018-2026

Report Code: SRHI26DR
Author : Straits Research

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Cancer Treatment Market Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    3. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Targeted Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Hormonal Therapy
        1. By Value
      6. Others
        1. By Value
    4. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Cancer & Radiation Therapy Centers
        1. By Value
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    3. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Targeted Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Hormonal Therapy
        1. By Value
      6. Others
        1. By Value
    4. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Cancer & Radiation Therapy Centers
        1. By Value
    5. U.S.
      1. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
      2. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Targeted Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Hormonal Therapy
          1. By Value
        6. Others
          1. By Value
      3. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Cancer & Radiation Therapy Centers
          1. By Value
    6. Canada
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    3. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Targeted Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Hormonal Therapy
        1. By Value
      6. Others
        1. By Value
    4. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Cancer & Radiation Therapy Centers
        1. By Value
    5. U.K.
      1. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
      2. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Targeted Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Hormonal Therapy
          1. By Value
        6. Others
          1. By Value
      3. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Cancer & Radiation Therapy Centers
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    3. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Targeted Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Hormonal Therapy
        1. By Value
      6. Others
        1. By Value
    4. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Cancer & Radiation Therapy Centers
        1. By Value
    5. China
      1. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
      2. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Targeted Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Hormonal Therapy
          1. By Value
        6. Others
          1. By Value
      3. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Cancer & Radiation Therapy Centers
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    3. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Targeted Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Hormonal Therapy
        1. By Value
      6. Others
        1. By Value
    4. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Cancer & Radiation Therapy Centers
        1. By Value
    5. UAE
      1. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
      2. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Targeted Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Hormonal Therapy
          1. By Value
        6. Others
          1. By Value
      3. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Cancer & Radiation Therapy Centers
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    3. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Targeted Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Hormonal Therapy
        1. By Value
      6. Others
        1. By Value
    4. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Cancer & Radiation Therapy Centers
        1. By Value
    5. Brazil
      1. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
      2. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Targeted Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Hormonal Therapy
          1. By Value
        6. Others
          1. By Value
      3. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Cancer & Radiation Therapy Centers
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Cancer Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. F. Hoffmann-La Roche AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Bristol-Myers Squibb Company
    3. AbbVie INC.
    4. Johnson & Johnson
    5. Celgene Corporation
    6. Astellas Pharma INC.
    7. Pfizer INC.
    8. Novartis AG
    9. Merck KGaA
    10. Eli Lilly
    11. AstraZeneca plc
    12. Bayer AG
    13. Takeda Pharmaceutical Company Limited.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer
Straits Research - Access Portal
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.



We are featured on :